ERY 500 mg, tablet 20 tablets
Active ingredients: Erythromycin propionate, Erythromycin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ERY 500 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 20 comprimé(s)
- Marketing authorisation holder
- BOUCHARA-RECORDATI
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1979
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61572941CIP73223887CIP133400932238873Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉRYTHROMYCINE BASEcomprimé | 500 mg · un comprimé | FT |
| PROPIONATE D'ÉRYTHROMYCINEcomprimé | 538 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.